ClinicalTrials.Veeva

Menu

Study of Biological Determinants of Bleeding Postpartum (HPP-IPF)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Postpartum Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT02884804
HPP-IPF (RB 11.080)

Details and patient eligibility

About

At the entry of the delivery room, a standard blood analysis will be performed (Blood count, PT, aPTT, Fibrinogen, and D-Dimer) for each women (if they are agree), according to the center's practices.

The percentage of the immature platelets is a an additional parameter on the hemogram.

The clinical assessments (recorded in medical records) and biological values will be used to determine if there is a correlation between these data and the occurrence of postpartum hemorrhage.

Enrollment

3,599 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Woman giving birth in a maternity of Finistère

Exclusion criteria

  • Refuse to participate in the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems